Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study

Table 2 The JIS prevalence of metabolic syndrome according to 10-year predicted risk of coronary heart disease, using the two waist circumference thresholds

Metabolic syndrome	Total	10-year CHD risk (FRS ≥ 20%) n (%) (95% CI)	P-value†
JIS-94/80
Yes	386	33 (8.55) (5.75 - 11.4)	< 0.0001
No	916	7 (0.76) (0.20 - 1.33)
JIS-102/88*
Yes	342	33 (9.65) (6.50 - 12.8)	< 0.0001
No	960	7 (0.73) (0.19 - 1.27)

* JIS-94/80 means the MS as defined by the lower thresholds of the WC criterion (94 cm for men and 80 cm for women). JIS-102/88 means the MS as defined by the higher thresholds of WC criterion (102 cm for men and 88 cm for women). JIS-102/88 corresponds exactly to the R-ATPIII definition. † P value indicates the comparison between the 10-year CHD risk classes according to the presence of the MS for each WC threshold.

ISSN: 1471-2458